Re: MannKind Corporation to Present at The 24th Annual Piper Jaffray Healthcare Conf
posted on
Nov 27, 2012 02:12PM
Edit this title from the Fast Facts Section
Overall, good Q & A session. We certainly need to be realistic with timelines. When they say resubmission in Q3, count on late September at the earliest. I am counting on stunning trial results, given the explanation of their design. I hope this is followed shortly by some firm partnership offers - companies won't want to miss the boat once they see the potential right in front of them. Then maybe we see some escalation in dealmaking!
Wells